2TZ fundamentals
An in-depth look to Tianjin Zhong Xin Pharmaceutical Group Corp. Ltd. operating, investing, and financing activities
2TZ free cash flow for Q1 24 is 8.65 M EUR. For 2023, 2TZ free cash flow was 92.81 M EUR and operating cash flow was 110.83 M EUR.
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
0.00
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: EUR
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
TTM